carnitine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, Y | 1 |
| Okano, K | 1 |
| Sato, K | 1 |
| Sugimoto, M | 1 |
| Shimomura, A | 1 |
| Nagao, M | 1 |
| Matsukawa, H | 1 |
| Ando, Y | 1 |
| Suto, H | 1 |
| Oshima, M | 1 |
| Kondo, A | 1 |
| Asano, E | 1 |
| Kishino, T | 1 |
| Kumamoto, K | 1 |
| Kobara, H | 1 |
| Kamada, H | 1 |
| Masaki, T | 1 |
| Soga, T | 1 |
| Suzuki, Y | 1 |
1 other study available for carnitine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.
Topics: Antigens, CD; Carcinoma, Pancreatic Ductal; Carnitine; Chemoradiotherapy; Glutathione; Humans; Neoad | 2022 |